9% Limitation Not Exceeded. The aggregate number of Put Shares to be issued in the Put, when combined with the number of shares of Common Stock of the Company then beneficially owned by the Investor, would not cause the Investor to exceed the 4.9% Limitation (as defined herein);
Appears in 9 contracts
Samples: Investment Agreement (Blue Sphere Corp.), Investment Agreement (Amarantus BioSciences, Inc.), Investment Agreement (Allezoe Medical Holdings Inc)
9% Limitation Not Exceeded. The aggregate number of Put Shares to be issued in the Put, when combined with the number of shares of Common Stock of the Company then beneficially owned by the Investor, would not cause the Investor to exceed the 4.99.9% Limitation (as defined herein);
Appears in 7 contracts
Samples: Investment Agreement (Dynamic Ventures Corp.), Investment Agreement (Vendum Batteries Inc.), Investment Agreement (Medisafe 1 Technologies Corp)
9% Limitation Not Exceeded. The aggregate number of Put Shares to be issued in the Put, when combined with the number of shares of Common Stock of the Company then beneficially owned by the InvestorCompany, would not cause the Investor to exceed the 4.9% Limitation (as defined herein);
Appears in 2 contracts
Samples: Investment Agreement (Li3 Energy, Inc.), Investment Agreement (Li3 Energy, Inc.)
9% Limitation Not Exceeded. The aggregate number of Put Shares to be issued in the Put, when combined with the number of shares of Common Stock of the Company then beneficially owned by the Investor, would not cause the Investor to exceed the 4.9% Limitation (as defined herein);; 19
Appears in 1 contract
